Search research articles
Contact Us
Filters
Showing results (11-20 of 53) with videos related to
Page
of 6
Sort By:
Cancers
|
July 24, 2019
Platelets as Key Factors in Hepatocellular Carcinoma
Natasa Pavlovic, Bhavna Rani, Pär Gerwins, et al.
The American Journal of Pathology
|
October 29, 2022
Endoplasmic Reticulum Stress and Metabolism in Hepatocellular Carcinoma
Clara Luna-Marco, Anna Ubink, Maria Kopsida, et al.
Therapeutic Advances in Medical Oncology
|
February 10, 2025
Gastrointestinal side effects in hepatocellular carcinoma patients receiving transarterial chemoembolization: a meta-analysis of 81 studies and 9495 patients
Nathalie Arendt, Maria Kopsida, Jaafar Khaled, et al.
European Journal of Pharmacology
|
October 25, 2025
Statin-mediated protection in chemotherapy-induced intestinal and cardiac toxicity: current perspectives
Nathalie Arendt, Maria Kopsida, Hans Lennernäs, et al.
Cancers
|
July 24, 2019
Liver Cancer Cell Lines Treated with Doxorubicin under Normoxia and Hypoxia: Cell Viability and Oncologic Protein Profile
Ilse R Dubbelboer, Natasa Pavlovic, Femke Heindryckx, et al.
Journal of Visualized Experiments : Jove
|
August 25, 2020
A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties
Carlemi Calitz, Nataša Pavlović, Jenny Rosenquist, et al.
Basic & Clinical Pharmacology & Toxicology
|
March 6, 2023
Anakinra and dexamethasone treatment of idarubicin-induced mucositis and diarrhoea in rats
Fredrik Kullenberg, Karsten Peters, Markus Sjöblom, et al.
Analytica Chimica Acta
|
July 5, 2024
Ammonium bicarbonate buffers combined with hybrid surface technology columns improve the peak shape of strongly tailing lipids
Jenny M Nilsson, David Balgoma, Curt Pettersson, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
December 5, 2025
A comparative study of idarubicin and doxorubicin in a chemically-induced in vivo mouse model for hepatocellular carcinoma
Ada Lerma-Clavero, Maria Kopsida, Nathalie Arendt, et al.
Therapeutic Advances in Medical Oncology
|
May 19, 2026
Prevalence of gastrointestinal side effects in hepatocellular carcinoma patients receiving sorafenib: a meta-analysis of 136 studies and 14,416 patients
Nathalie Arendt, Tania Payo-Serafín, Anna Kolosenko, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 53) with videos related to
Sort By:
Page
of 6
Cancers
|
July 24, 2019
Platelets as Key Factors in Hepatocellular Carcinoma
Natasa Pavlovic, Bhavna Rani, Pär Gerwins, et al.
The American Journal of Pathology
|
October 29, 2022
Endoplasmic Reticulum Stress and Metabolism in Hepatocellular Carcinoma
Clara Luna-Marco, Anna Ubink, Maria Kopsida, et al.
Therapeutic Advances in Medical Oncology
|
February 10, 2025
Gastrointestinal side effects in hepatocellular carcinoma patients receiving transarterial chemoembolization: a meta-analysis of 81 studies and 9495 patients
Nathalie Arendt, Maria Kopsida, Jaafar Khaled, et al.
European Journal of Pharmacology
|
October 25, 2025
Statin-mediated protection in chemotherapy-induced intestinal and cardiac toxicity: current perspectives
Nathalie Arendt, Maria Kopsida, Hans Lennernäs, et al.
Cancers
|
July 24, 2019
Liver Cancer Cell Lines Treated with Doxorubicin under Normoxia and Hypoxia: Cell Viability and Oncologic Protein Profile
Ilse R Dubbelboer, Natasa Pavlovic, Femke Heindryckx, et al.
Journal of Visualized Experiments : Jove
|
August 25, 2020
A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties
Carlemi Calitz, Nataša Pavlović, Jenny Rosenquist, et al.
Basic & Clinical Pharmacology & Toxicology
|
March 6, 2023
Anakinra and dexamethasone treatment of idarubicin-induced mucositis and diarrhoea in rats
Fredrik Kullenberg, Karsten Peters, Markus Sjöblom, et al.
Analytica Chimica Acta
|
July 5, 2024
Ammonium bicarbonate buffers combined with hybrid surface technology columns improve the peak shape of strongly tailing lipids
Jenny M Nilsson, David Balgoma, Curt Pettersson, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
December 5, 2025
A comparative study of idarubicin and doxorubicin in a chemically-induced in vivo mouse model for hepatocellular carcinoma
Ada Lerma-Clavero, Maria Kopsida, Nathalie Arendt, et al.
Therapeutic Advances in Medical Oncology
|
May 19, 2026
Prevalence of gastrointestinal side effects in hepatocellular carcinoma patients receiving sorafenib: a meta-analysis of 136 studies and 14,416 patients
Nathalie Arendt, Tania Payo-Serafín, Anna Kolosenko, et al.
Page
of 6